Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06960616 · ClinicalTrials.gov registry record · NA

Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy

A NA study of Deafness and Cochlear Hearing Loss, sponsored by Massachusetts Eye and Ear Infirmary.

Recruiting
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT06960616 is a NA study of Deafness and Cochlear Hearing Loss that is actively recruiting participants, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 48 participants, below the 613-participant average among 11 other Deafness trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06960616, a NA study of Deafness and Cochlear Hearing Loss, is actively recruiting participants, sponsored by Massachusetts Eye and Ear Infirmary.

RECRUITING
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

The study is about the importance of each follow-up visit after activating a new cochlear implant in addition to evaluating the effectiveness and efficiency of a new programming strategy from Cochlear Americas. Investigators are looking for patients who have recently selected Cochlear Americas as their cochlear implant manufacturer of choice for their upcoming surgery. The aim of this study is to determine if 1) patient outcomes remain stable when reducing follow-up appointments and 2) Cochlear's population mean mapping can produce similar outcomes with patients while additionally reducing appointment times. The hypothesis is that using population mean mapping and reducing the number of follow-up visits after activation will yield similar performance outcomes to a standard of care while decreasing the length of appointment times and number of appointments needed for each patient.

Interventions

  • OTHER Changes in traditional follow-up
  • OTHER Population mean mapping

Study Locations (1)

Massachusetts

  • Mass Eye and Ear - Boston

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2024-02-27
Est. Completion 2026-02-26
Phase NA

What the Registry Record Tells You About NCT06960616

The ClinicalTrials.gov registry entry for NCT06960616 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 613-participant average among 11 other Deafness trials with a reported enrollment target (92% lower). The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Deafness appearing as the primary indexed condition, and to 2 interventions - of which Changes in traditional follow-up is the first listed.

NCT06960616 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06960616 about?

NCT06960616 is a clinical study titled "Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy". The study is about the importance of each follow-up visit after activating a new cochlear implant in addition to evaluating the effectiveness and efficiency of a new programming strategy from Cochlear Americas. Investigators are looking for patients who have recently selected Cochlear Americas as th...

What is the current status of trial NCT06960616?

This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2024-02-27. Estimated completion is 2026-02-26.

What conditions does trial NCT06960616 study?

This clinical trial studies the following conditions: Deafness, Cochlear Hearing Loss.

What interventions are being tested in trial NCT06960616?

The interventions under investigation include: Changes in traditional follow-up (OTHER), Population mean mapping (OTHER).

Who is sponsoring clinical trial NCT06960616?

This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06960616 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Deafness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.